Abstract 1865P
Background
This study aimed to determine how the chemotherapy process can lead to a change in self-esteem in elderly patients with early-stage breast cancer according to personality type.
Methods
The research was completed as a pilot study between 2019-2022. Female patients aged 65 and over who were planned for adjuvant treatment were included in the study. Personality type and self-esteem were determined in all patients before and after adjuvant chemotherapy. Bortner Rating Scale was used to determine personality type, and Rosenberg Self-Esteem Scale was used to determine self-confidence. Paired t-test was performed for recurrent variables in pre-treatment and post-treatment measures. Multivariate logistic (binary) regression analysis was performed to determine the independent factors affecting low self-esteem from the study variables with the model created as a result of correlation and univariate analysis. Statistical analysis was performed using the SPSS v19 program and a p value of <0.05 was considered statistically significant.
Results
A total of 69 Her2-negative elderly female patients were included in this pilot study. The mean age of the patients was 68 years (65-72). 54% had radical mastectomy. 69% received paclitaxel for 12 weeks, 21% received 6x DC, and 10% received 3x CEF followed by 3x docetaxel for adjuvant setting. 56% of them had personality type A. Before treatment, 62% had high self-esteem and this was significantly higher in type A personality than in type B (84% vs 48%, respectively; p=0.037). While the rate of high self-esteem decreased in type A personality after treatment (p=0.009), there was no change in type B personality (p=0.379). It was determined that type A personality structure was independent affecting low self-esteem after treatment (OR 5.37 95%CI 1.489-9.396; p=0.006).
Conclusions
In this study, it was concluded that elderly women with type A personality structure may be more sensitive and may have low self-esteem after the treatment is completed. It was concluded that the personality type should be guided by the patient's treatment compliance, need for psychosocial support, and coping methods after the completion of the treatment, supported by the physician.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Ethics committee approval could not be obtained because it was a pilot study. In the follow-up research, the results of the pilot study will be declared and consent will be obtained.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
1855P - Assessment of depression and anxiety among adult patients with solid tumours admitted in national institute of cancer research & hospital
Presenter: Salman Al Ayub
Session: Poster session 05
1857P - Psychological distress in Georgian cancer patients undergoing chemotherapy: Before and after the COVID-19 pandemic
Presenter: Mariam Abuladze
Session: Poster session 05
1858P - Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis
Presenter: Dalyong Kim
Session: Poster session 05
1859P - Digital goal management training as treatment for cognitive impairment in cervical cancer survivors: A feasibility study
Presenter: Elisabeth Areklett
Session: Poster session 05
1860P - Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Presenter: Nathalie Vanlaer
Session: Poster session 05
1861P - A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
Presenter: Simon Spahrkäs
Session: Poster session 05
1862P - Measuring the prevalence of fatigue in children with cancer: Evidence from Egypt
Presenter: Nourhan Abdalkader
Session: Poster session 05
1863P - Compassion fatigue among the staff involved in medical carcinology services
Presenter: Nouha Abidi
Session: Poster session 05
1864P - To what extent do nulliparous, female adolescents and young adults diagnosed with cancer have children after cancer treatment?
Presenter: Line Bentsen
Session: Poster session 05
1866P - Unmasking the extent of hidden sexual distress in young breast cancer survivors
Presenter: Zeineb Naimi
Session: Poster session 05